News Lipidor AB

Equities

LIPI

SE0012558617

Market Closed - Nasdaq Stockholm Other stock markets 11:18:41 2024-04-29 am EDT			5-day change	1st Jan Change
0.25 ^SEK	+6.38%		+6.38%	-50.40%

Mar. 21	Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	CI
Feb. 28	Lipidor AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lipidor AB announces new date for publication of Annual Report 2023	Apr. 22	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)	Apr. 10	AQ
Lipidor resolves on a rights issue of approximately SEK 58.0 million and enters into a co-investment agreement which secures funding for the implementation of the upcoming phase III study	Apr. 10	AQ
Lipidor completes planned divestment of shares in Emollivet	Mar. 26	AQ
Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2	Mar. 21	AQ
Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	Mar. 21	CI
Lipidor adds capital through sale of shares	Mar. 06	AQ
Lipidor AB (publ) publishes year-end report for 2023	Feb. 28	AQ
Lipidor AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Lipidor completes SEK 1.7 million sale of animal segment patent	Jan. 24	AQ
Lipidor adds 1.1 MSEK through sale of shares in associated company and agreement of loan	Dec. 21	AQ
Lipidor Seeks Approval for Late-stage Study of Plaque Psoriasis Medicine in India	Dec. 20	MT
Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2	Dec. 20	AQ
Lipidor Applies to the Indian Medical Products Agency to Start A Phase III study of AKP02G2	Dec. 20	CI
Lipidor presents Nomination Committee	Dec. 05	AQ
Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)	Nov. 30	AQ
Lipidor AB (publ) publishes interim report for Q3 2023	Nov. 22	AQ
Lipidor AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 22	CI
Lipidor Files New Patent Application for Akvano Technology in EU	23-10-27	MT
Lipidor submits new patent application	23-10-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lipidor AB

Equities

LIPI

SE0012558617

Summary

Filters